✦ LIBER ✦

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

✍ Scribed by Houston, S J; Plunkett, T A; Barnes, D M; Smith, P; Rubens, R D; Miles, D W

Book ID: 110001058
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 104 KB
Volume: 79
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6690196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between c-erbB-2 protein pr

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

✍ Wright, C; Nicholson, S; Angus, B; Sainsbury, JRC; Farndon, J; Cairns, J; Harris 📂 Article 📅 1992 🏛 Nature Publishing Group 🌐 English ⚖ 653 KB

MicroRNA-30c expression level is an inde

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

✍ F. Germán Rodríguez-González; Anieta M. Sieuwerts; Marcel Smid; Maxime P. Look; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 313 KB

Downregulation of SIAH2, an ubiquitin E3

Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer

✍ Maurice P. H. M. Jansen; Kirsten Ruigrok-Ritstier; Lambert C. J. Dorssers; Iris 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 351 KB

Assessment of response to therapy in adv

Assessment of response to therapy in advanced breast cancer (an amendment)

✍ Hayward, J L; Carbone, P P; Rubens, R D; Heuson, J C; Kumaoka, S; Segaloff, A 📂 Article 📅 1978 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Overexpression of both p185c-erbB2 and p

Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol

✍ Ibrahim, Nuhad; Hortobagyi, Gabriel N; Hung, Mien-Chie; Yu, Dihua; Liu, Bolin; J 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 390 KB

The p53 positive Bcl-2 negative phenotyp

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer

✍ Phil Rolland; Ian Spendlove; Zahra Madjid; Emad A. Rakha; Poulam Patel; Ian O. E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 275 KB

## Abstract The purpose of this work was to determine if the immunohistochemical p53 (+) Bcl‐2 (−) phenotype predicts survival in breast cancer patients. Tissue from 819 cases of resected primary breast cancer, presented between 1986 and 1998, were assembled in tissue microarray format. Clinicopath